May 27, 2024 – Amphithéatre Duclaux – Institut Pasteur
This year, we will have the pleasure to welcome Dr Bernhard Hube, from Leibniz-Hans Knöll Institute in Germany. Dr Hube will present his work on “The commensal-to-pathogen shift of Candida albicans”.
Bernhard Hube earned his PhD in Microbiology at the University of Goettingen (1991) and spent his postdoctoral time at the University of Aberdeen (1992 – 1995) and the University of Hamburg (1995 – 2000). In 2000 he became Research Group leader and Head of Division “Mycology”, at the Robert Koch Institute, Berlin. In 2006 he was appointed Professor and Chair for Microbial Pathogenicity at the Friedrich Schiller University of Jena, and in 2007 Head of the Department of Microbial Pathogenicity Mechanisms at the Leibniz-HKI in Jena, Germany. He has co-authored > 300 publications dealing with the molecular and infection biology of human pathogenic fungi, in particular Candida species. He discovered one of the first virulence genes, encoding a secreted aspartic proteinase, in C. albicans. His recent research focuses on the first peptide toxin discovered in human pathogenic fungi, candidalysin.
Discover the work of the Labex IBEID partners through the scientific oral presentations.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.